Invention Grant
- Patent Title: Phosphodiesterase inhibitors and uses thereof
-
Application No.: US14905246Application Date: 2014-07-17
-
Publication No.: US10899756B2Publication Date: 2021-01-26
- Inventor: Donald W. Landry , Shixian Deng , Ottavio Arancio , Jole Fiorito , Andrew Wasmuth
- Applicant: The Trustees of Columbia University in the City of New York
- Applicant Address: US NY New York
- Assignee: The Trustees of Columbia University in the City of New York
- Current Assignee: The Trustees of Columbia University in the City of New York
- Current Assignee Address: US NY New York
- Agency: Wilmer Cutler Pickering Hale and Dorr LLP
- International Application: PCT/US2014/047031 WO 20140717
- International Announcement: WO2015/009930 WO 20150122
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D471/14

Abstract:
The invention provides for novel benzonaphthyridine derivatives and compositions comprising novel benzonaphthyridine derivatives. In some embodiments, the compounds are phosphodiesterase inhibitors. The invention further provides for methods for inhibition of phosphodiesterase comprising contacting phosphodiesterase with novel benzonaphthyridine derivatives or compositions comprising novel benzonaphthyridine derivatives. The invention further provides for methods for treatment of neurodegenerative diseases, increasing memory or long term potentiation with novel benzonaphthyridine derivatives or compositions comprising novel benzonaphthyridine derivatives. In some embodiments, the phosphodiesterase is PDE5.
Public/Granted literature
- US20160152612A1 NOVEL PHOSPHODIESTERASE INHIBITORS AND USES THEREOF Public/Granted day:2016-06-02
Information query